An observational, population-based cohort design study to evaluate utilisation of a new once weekly injection for type 2 diabetes mellitus.

Trial Profile

An observational, population-based cohort design study to evaluate utilisation of a new once weekly injection for type 2 diabetes mellitus.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2015 New trial record
    • 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top